Stock DYN DYNE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Dyne Therapeutics, Inc.

Equities

DYN

US26818M1080

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
24.73 USD +4.37% Intraday chart for Dyne Therapeutics, Inc. +3.65% +85.94%
Mar. 25 Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell MT
Mar. 25 Dyne Therapeutics, Inc. Announces Management Changes CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell
Dyne Therapeutics, Inc. Announces Management Changes
Dyne Therapeutics, Inc. Announces Chief Executive Officer Changes
Dyne Therapeutics Insider Sold Shares Worth $1,398,347, According to a Recent SEC Filing
Dyne Therapeutics's Q4 Net Loss Widens; Shares Down Pre-Bell
Dyne Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Dyne Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Dyne Therapeutics Insider Sold Shares Worth $2,895,519, According to a Recent SEC Filing
Dyne Therapeutics Insider Sold Shares Worth $811,865, According to a Recent SEC Filing
Dyne Therapeutics Insider Sold Shares Worth $357,296, According to a Recent SEC Filing
Dyne Therapeutics Insider Sold Shares Worth $19,626,903, According to a Recent SEC Filing
Dyne Therapeutics Insider Sold Shares Worth $490,510, According to a Recent SEC Filing
Dyne Therapeutics Insider Sold Shares Worth $316,420, According to a Recent SEC Filing
Dyne Therapeutics Reportedly Seeing Takeover Interest, Weighing Options
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Dyne Therapeutics Insider Bought Shares Worth $29,999,988, According to a Recent SEC Filing
Dyne Therapeutics Raises $345.1 Million From Share Offering
Dyne Therapeutics Insider Sold Shares Worth $1,629,985, According to a Recent SEC Filing
Dyne Therapeutics Insider Sold Shares Worth $529,194, According to a Recent SEC Filing
MORNING BRIEFING - USA/Asien
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DYN Stock
  4. News Dyne Therapeutics, Inc.
  5. Other languages